Inhibition of nuclear factor-κb activation in mouse macrophages and the RAW 264.7 cell line by a synthetic adenyl carbocyclic nucleoside

Biochemical Pharmacology

Volumn 60, Issue 5, 2000, Pages 717-727

  Xia, Dongxiang ^a   Wang, Fuan ^a   Parmely, Michael J ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Adenyl carbocyclic nucleoside; I B ; NF B; TNF

Indexed keywords

9 (3 HYDROXYCYCLOPENTYL)ADENINE; BACTERIUM LIPOPOLYSACCHARIDE; CARBOCYCLIC NUCLEOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL LINE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENINE; ANIMALS; CELL NUCLEUS; CELLS, CULTURED; I-KAPPA B PROTEINS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NUCLEOPROTEINS; PEPTIDES; TRANS-ACTIVATION (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034285061     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00367-1     Document Type: Article

References (53)

1. Parmely M.J., Zhou W.-W., Edwards C.K. III, Borcherding D.R., Silverstein R., Morrison D.C. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-α production and protect mice against endotoxin challenge. J Immunol. 151:1993;389-396.
2. Mountz J.D., Baker T.J., Borcherding D.R., Bluethmann H., Zhou T., Edwards C.K. III. Increased susceptibility of fas mutant MLR-lpr/lpr mice to staphylococcal enterotoxin B-induced septic shock. J Immunol. 155:1995;4829-4837.
3. Borcherding D.R., Peet N.P., Munson H.R., Zhang H., Hoffman P.F., Bowlin T.L., Edwards C.K. III. Carbocyclic nucleosides as inhibitors of human tumor necrosis factor-α production Effects of the stereoisomers of (3-hydroxycyclopentyl)adenines. J Med Chem. 39:1996;2615-2620.
4. Parmely M.J., Hao S.-Y., Morrison D.C., Pace J.L. Role of macrophage-derived nitric oxide in endotoxin lethality in mice. J Endotoxin Res. 2:1995;45-52.
5. + antigen expression. J Leukoc Biol. 56:1994;133-144.
6. Bradshaw M., Rutherford M.S., Hoeper B.J., McWhinney C.D., Borcherding D.R., Schook L.B., Edwards C.K. III. Specific transcriptional inhibition of bone marrow-derived macrophage tumor necrosis factor-α gene expression and protein production using novel enantiomeric carbocyclic nucleoside analogues. J Pharmacol Exp Ther. 273:1995;1506-1518.
7. Shakhov A.N., Collart M.A., Vassalli P., Nedospasov S.A., Jongeneel C.V. κB-Type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J Exp Med. 171:1990;35-47.
8. Drouet C., Shakhov A.N., Jongeneel C.V. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-α promoter in primary macrophages. J Immunol. 147:1991;1694-1700.
9. Kuprash D.V., Udalova I.A., Turetskaya R.L., Rice N.R., Nedospasov S.A. Conserved κB element located downstream of the tumor necrosis factor α gene Distinct NF-κB binding pattern and enhancer activity in LPS activated murine macrophages. Oncogene. 11:1995;97-106.
10. Jongeneel C.V. and lymphotoxin promoters. Beutler B. Tumor Necrosis Factors The Molecules and Their Emerging Roles in Medicine. 1992;539-559 Raven Press, New York.
11. Collart M.A., Baeuerle P., Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages Involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol Cell Biol. 10:1990;1498-1506.
12. Rice N.R., Ernst M.K. In vivo control of NF-κB activation by IκBα EMBO J. 12:1993;4685-4695.
13. Beg A.A., Baldwin A.S. The IκB proteins Multifunctional regulation of Rel/NF-κB transcription factors. Genes Dev. 7:1993;2064-2070.
14. Beauparlant P., Hiscott J. Biological and biochemical inhibitors of the NF-κB/Rel proteins and cytokine synthesis. Cytokine Growth Factor Rev. 7:1996;175-190.
15. Hausmann E.H.S., Hao S.-Y., Pace J.L., Parmely M.J. Transforming growth factor β1 and gamma interferon provide opposing signals to lipopolysaccharide-activated mouse macrophages. Infect Immun. 62:1994;3625-3632.
16. Parmely M.J., Gale A., Clabaugh M., Horvat R.T., Zhou W.-W. Proteolytic inactivation of cytokines by Pseudomonas aeruginosa. Infect Immun. 58:1990;3009-3014.
17. Schreiber E., Matthias P., Muller M.M., Schaffner W. Rapid detection of octamer binding proteins with ’mini-extracts’, prepared from a small number of cells. Nucleic Acids Res. 17:1989;6419.
18. Zheng S., Brown M.C., Taffet S.M. Lipopolysaccharide stimulates both nuclear localization of the nuclear factor κB 50-kDa subunit and loss of the 105-kDa precursor in RAW264 macrophage-like cells. J Biol Chem. 268:1993;17233-17239.
19. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
20. Muroi M., Muroi Y., Yamamoto K., Suzuki T. Influence of 3′ half-site sequence of NF-κB motifs on the binding of lipopolysaccharide-activatable macrophage NF-κB proteins. J Biol Chem. 268:1993;19534-19539.
21. Xia D., Straus S.E. Transcript mapping and transregulatory behavior of varicella-zoster virus gene 21, a latency-associated gene. Virology. 258:1999;304-313.
22. Wang F., Wang L.Y., Wright D., Parmely M.J. Redox imbalance differentially inhibits lipopolysaccharide-induced macrophage activation in the mouse liver. Infect Immun. 67:1999;5409-5416.
23. Jeong J.-Y., Kim K.-U., Jue D.-M. Tosylphenylalanine chloromethyl ketone inhibits TNF-α mRNA synthesis in the presence of activated NF-κB in RAW 264.7 macrophages. Immunology. 92:1997;267-273.
24. Traenckner E.B.-N., Wilk S., Baeuerle P.A. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκBα that is still bound to NF-κB. EMBO J. 13:1994;5433-5441.
25. Lin Y.C., Brown K., Siebenlist U. Activation of NF-κB requires proteolysis of the inhibitor IκBα Signal-induced phosphorylation of IκBα alone does not release active NF-κB. Proc Natl Acad Sci USA. 92:1995;552-556.
26. Beg A.A., Finco T.S., Nantermet P.V., Baldwin A.S. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBα A mechanism for NF-κB activation. Mol Cell Biol. 13:1993;3301-3310.
27. Pimentel-Muinos F.X., Mazana J., Fresno M. Biphasic control of nuclear factor-κB activation by the T cell receptor complex Role of tumor necrosis factor α Eur J Immunol. 25:1995;179-186.
28. Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent pathways. J Immunol. 141:1988;2407-2412.
29. Ohmori Y., Hamilton T.A. The interferon-stimulated response element and a κB site mediate synergistic induction of murine IP-10 gene transcription by IFN-γ and TNF-α J Immunol. 154:1995;5235-5244.
30. Tebo J.M., Chaoqun W., Ohmori Y., Hamilton T.A. Murine inhibitory protein-κBα negatively regulates κB-dependent transcription in lipopolysaccharide-stimulated RAW 264.7 macrophages. J Immunol. 153:1994;4713-4720.
31. Muroi M., Muroi Y., Ito B.N., Rice N.R., Suzuki T. Effects of protease inhibitors on LPS-mediated activation of a mouse macrophage cell line (J774). J Endotoxin Res. 2:1995;337-347.
32. Parmely M.J., Hausmann E.H.S., Morrison D.C. Carbocyclic nucleosides as potential therapeutic agents for the treatment of septic shock. Morrison D.C., Ryan J.L. Novel Therapeutic Strategies in the Treatment of Sepsis. 1996;253-265 Marcel Dekker, New York.
33. Scheinman R.I., Cogswell P.C., Lofquist A.K., Baldwin A.S. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science. 270:1995;283-286.
34. Auphan N., DiDonato J.A., Rosette C., Helmberg A., Karin M. Immunosuppression by glucocorticoids Inhibition of NF-κB activity through induction of IκBα synthesis. Science. 270:1995;286-290.
35. Kopp E., Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science. 265:1994;956-959.
36. Mackman N. Protease inhibitors block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of c-Rel/p65 heterodimers. J Biol Chem. 269:1994;26363-26367.
37. Kim H., Lee H.S., Chang K.T., Ko T.H., Baek K.J., Kwon N.S. Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-κB. J Immunol. 154:1995;4741-4748.
38. Toledano M.B., Leonard W.J. Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci USA. 88:1991;4328-4332.
39. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells AP-1 as secondary antioxidant-responsive factor. EMBO J. 12:1993;2005-2012.
40. Ziegler-Heitbrock H.W.L., Sternsdorf T., Liese J., Belohradshy B., Wever C., Wedel A., Schreck R., Bauerle P., Strobel M. Pyrrolidine dithiocarbamate inhibits NF-κB mobilization and TNF production in human monocytes. J Immunol. 151:1993;6986-6993.
41. Kumar S., Rabson A.B., Gélinas C. The RxxRxRxxC motif conserved in all Rel/κB proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein. Mol Cell Biol. 12:1992;3094-3106.
42. Peng H.-B., Lin H.L., Liao K. Induction and stabilization of IκBα by nitric oxide mediates inhibition of NF-κB. J Biol Chem. 270:1995;14214-14219.
43. Park K.K., Lin H.L., Murphy S. Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-κB binding to DNA. Biochem J. 322:1997;609-613.
44. Togashi H., Sasaki M., Frohman E., Taira E., Ratan R.R., Dawson T.M., Dawson V.L. Neuronal (type I) nitric oxide synthase regulates nuclear factor κB activity and immunologic (type II) nitric oxide synthase expression. Proc Natl Acad Sci USA. 94:1997;2676-2680.
45. Singh S., Natarajan K., Aggarwal B.B. Capsaicin (8-methyl-N-vanillyl-6-noneamide) is a potent inhibitor of nuclear transcription factor-κB activation by diverse agents. J Immunol. 157:1996;4412-4420.
46. De Bosscher K., Schmitz M.L., Vanden Berghe W., Plaisance S., Fiers W., Haegeman G. Glucocorticoid-mediated repression of nuclear factor-κB-dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci USA. 94:1997;13504-13509.
47. Sajjadi F.G., Takabayashi K., Foster A.C., Domingo R.C., Firestein G.S. Inhibition of TNF-α expression by adenosine. Role of A3 adenosine receptors. J Immunol. 156:1996;3435-3442.
48. Ollivier V., Parry G.C.N., Cobb R.R., de Prost D., Mackman N. Elevated cyclic AMP inhibits NF-κB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem. 271:1996;20828-20835.
49. Yao J., Mackman N., Edgington T.S., Fan S.-T. Lipopolysaccharide induction of tumor necrosis factor-α promoter in human monocytic cells. Regulation by Erg-1, c-Jun, and NF-κB transcription factors. J Biol Chem. 272:1997;17795-17801.
50. 1 and phorbol ester-stimulated activity in intact cells. J Biol Chem. 270:1995;15576-15584.
51. Finco T.S., Beg A.A., Baldwin A.S. Inducible phosphorylation of IκBα is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors. Proc Natl Acad Sci USA. 91:1994;11884-11888.
52. Mahon T.M., O’Neill L.A.J. Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-κB activation in T lymphocytes. Evidence for covalent modification of the p50 subunit. J Biol Chem. 270:1995;28557-28564.
53. Matthews J.R., Botting C.H., Panico M., Morris H.R., Hay R.T. Inhibition of NF-κB DNA binding by nitric oxide. Nucleic Acids Res. 24:1996;2236-2242.